Vorsitz: J. Seeger (Friedrichshafen), B. Toprak (Hamburg)
| (V424) | GLP-1 levels are associated with cardiovascular and all-cause mortality in patients undergoing coronary angiography: the LURIC study | |
| F. Kahles, M. Reugels, M. E. Kleber, W. März, N. Marx, M. Lehrke (Aachen, Mannheim) | ||
| Diskussion | ||
| (V425) | Bioactive adrenomedullin and mortality in patients with high cardiovascular risk | |
| F. Kahles, M. Rau, O. Hartmann, F. D. Lobo da Fonseca de Sá, J. Möllmann, B. Kurt, J. Spießhöfer, N. Marx, M. Lehrke (Aachen, Hennigsdorf) | ||
| Diskussion | ||
| (V426) | Characterisation of free amino acid supplementation as protection against posttranslational modifications (PTMs) in CVD and CKD | |
| D. Mikolajetz, S. Laudy, S. Orth-Alampour, V. Jankowski, J. Jankowski (Aachen) | ||
| Diskussion | ||
| (V427) | Serum levels of the endoplasmic-reticulum-stress chaperone GRP78 are associated with inflammation, identify patients with coronary artery disease and predict mortality | |
| M. Al Zaidi, E. Repges, S. Sommer-Weisel, F. Jansen, S. Zimmer, V. Tiyerili, G. Nickenig, A. Aksoy (Bonn, Dortmund) | ||
| Diskussion |
| 09:30 - 11:00 | Pause - Posterdiskussion |